NOTCH2 and systemic lupus erythematosus: Effectively, aberrant Notch2 signaling has been observed in clinical samples of patients affected by RA [11,12,13,14,15,16,17], systemic lupus erythematosus (SLE) [18,19], and systemic sclerosis [20].